News

US FDA approves first at-home test for cervical cancer screening
The U.S. Food and Drug Administration has approved the first at-home test for cervical cancer screening, its maker Teal ...
US FDA permits use of three natural-source colors in food items
The U.S. Food and Drug Administration said on Friday that it had granted permissions to three new color additives, marking ...
US FDA approves Verastem's ovarian cancer therapy
The U.S. Food and Drug Administration has approved Verastem's combination therapy for patients with a rare type of ovarian ...
US FDA centers to deploy AI internally, following experimental run
The U.S. Food and Drug Administration said on Thursday all its centers will deploy artificial intelligence internally ...
Novavax says talks with FDA on COVID vaccine approval ongoing calming investor fears
Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
US judge sides with FDA's removal of Lilly's weight loss drug from shortage list
A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...
US FDA advisers to discuss COVID-19 vaccine recommendations on May 22
The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...
Viatris' pain drug meets main goals of two late-stage trials
Viatris said on Thursday that its fast-acting form of generic pain drug meloxicam met the main goals of two late-stage studies.
OpenAI and US FDA hold talks about using AI in drug evaluation, Wired reports
OpenAI and the U.S. Food and Drug Administration have been meeting to discuss the health regulator's use of AI, technology ...
US FDA names agency critic Vinay Prasad as top vaccine official
The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and ...
J&J's oral psoriasis drug helps patients achieve clear skin in late-stage study
Johnson & Johnson said on Friday its experimental psoriasis drug met the main goal of a late-stage study, as the once-daily ...
Drug maker Recordati's Q1 revenue rises 11.9%, confirms 2025 guidance
Italian drug maker Recordati posted an 11.9% increase in its first-quarter net revenue on Thursday to 680.0 million euros ($767.52 million) and confirmed its guidance for 2025.